Spencer Marsh

Chief Scientific Officer The Tiny Cargo Company

Dr. Spencer Marsh is the Chief Scientific Officer of The Tiny Cargo Company. Dr. Marsh received his Ph.D. in Biomedical Engineering from Clemson University, then performed his postdoctoral research at the Fralin Biomedical Research Institute at Virginia Tech Carilion. During his postdoctoral time, he patented 5 inventions that now comprise Tiny Cargo’s core IP portfolio. Dr. Marsh leads the R&D, Regulatory, Manufacturing, QA/QC and non-dilutive programs at Tiny Cargo. Dr. Marsh has worked with exosomes for nearly 15 years and has been the primary source of innovation in the milk exosome field, with Tiny Cargo being the first company to scale milk exosome purification to industrial scales, and the first to enter Clinical Trials using milk exosomes as a carrier for a therapeutic to treat against exposure to lethal doses of radiation

Seminars

Thursday 24th September 2026
Assessing the Preclinical to Clinical Translation of XOlacta
2:00 pm
  • Analyzing loading efficiency assessment and PK/PD evaluation
  • Understanding the IND process for lethal indications
  • Overview of clinical assessments of XOlacta
Spencer Marsh - Expert Speaker - 8th Exosome-Based Therapeutic Development Summit